跳至主要内容
临床试验/NCT07683364
NCT07683364尚未招募不适用

Construction and Evaluation of a Bristol Stool Form Scale-Based Nursing Care Pathway for Enteral Nutrition-Associated Diarrhea in Critically Ill Patients: A Prospective, Randomized, Controlled, Single-Center Trial

Tang-Du Hospital1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2026年6月15日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
Severity of enteral nutrition-associated diarrhea

研究概览

简要总结

Enteral nutrition-associated diarrhea (ENAD) is one of the most common gastrointestinal complications in critically ill patients receiving enteral nutrition, with a reported incidence of 22.3%-63.1%. Current management lacks a standardized nursing process and relies on individual nurse experience. This study constructs a standardized nursing care pathway driven by the Bristol Stool Form Scale (BSFS) and evaluates, in a prospective randomized controlled design, whether it reduces the severity of ENAD compared with routine ICU care. Eligible mechanically fed ICU patients are randomized 1:1 to the care-pathway group or the routine-care group, observed for 7 days (D1-D7) with a follow-up assessment on D14. The primary endpoint is the Hart diarrhea score over the observation period.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ICU critically ill patient (APACHE II score ≥15).
  • Receiving enteral nutrition via nasogastric or nasojejunal tube.
  • No diarrhea in the 24 hours before enrollment (stool frequency <3/day or BSFS type <5).
  • Written informed consent provided by the patient or legal representative.

排除标准

  • Known allergy to components of the enteral nutrition formula used.
  • Organic bowel disease such as inflammatory bowel disease or short bowel syndrome.
  • Pre-existing diarrhea at enrollment (≥3 stools/24 h and BSFS type ≥5).
  • Severe hepatic insufficiency.
  • Clostridioides difficile infection or other stool-culture-confirmed infectious diarrhea.
  • Pregnant or lactating women.
  • Currently participating in another clinical study.
  • Any other condition deemed unsuitable by the investigator.

结局指标

主要结局

Severity of enteral nutrition-associated diarrhea

时间窗: Daily across the observation period (Day 1 to Day 7)

Diarrhea severity rated by the Hart scoring method; each stool over 24 h is scored and summed for a daily total; total ≥12 indicates diarrhea. Rated by independent blinded assessors.

Incidence of ENAD

时间窗: Day 1 to Day 7

Proportion meeting the diarrhea definition (Hart ≥12, or ≥3 stools/24 h with BSFS ≥5, or stool ≥500 g/24 h).

次要结局

  • Duration of diarrhea(Day 1 to Day 7)
  • Incidence and severity of incontinence-associated dermatitis(Day 1 to Day 7)
  • ICU length of stay(Through study completion, up to Day 14)

研究者

发起方
Tang-Du Hospital
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验